NCT07444541 2026-04-16
ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer
Anova Innovation Limited
Phase 1/2 Not yet recruiting
Anova Innovation Limited
Ohio State University Comprehensive Cancer Center
NRG Oncology
ImmunityBio, Inc.
FutureGen Biopharmaceutical (Beijing) Co., Ltd
Helsinki University Central Hospital
Affiliated Hospital of Guangdong Medical University